An invitation for comprehensive single-compound reviews on the pharmacological properties of newly launched drugs

Author： Michel Martin Hegde Sharath Hoyer Daniel Trifilieff Alexander

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.386, Iss.12, 2013-12, pp. : 1019-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Studying plant-derived coumarins for their pharmacological and therapeutic properties as potential anticancer drugs

By Kostova Irena

Expert Opinion on Drug Discovery, Vol. 2, Iss. 12, 2007-12 ,pp. : 1605-1618

Informa Healthcare

Access to resources Recommend Favorite

Cannabinoid pharmacological properties common to other centrally acting drugs

By Wiley J.L. Martin B.R.

European Journal of Pharmacology, Vol. 471, Iss. 3, 2003-06 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1898-1922

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 685-696

Bentham Science Publishers

Access to resources Recommend Favorite

Omacetaxine mepesuccinate (synribo) – newly launched in chronic myeloid leukemia

By Nazha Aziz Kantarjian Hagop Cortes Jorge Quintás-Cardama Alfonso

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1977-1986

Informa Healthcare

Access to resources Recommend Favorite